Is Pharma Really “Listening” to Patients on Social Media?
After criticizing Astrazeneca's @AZHelps Twitter account as being a poor model for use of social media by the pharmaceutical industry (see @AZHelps: Is This a Good Model for Pharma Use of...
@AZHelps: Is This a Good Model for Pharma Use of Social Media?
Recently, @jilliantate (Jullian Tate), Director, digital strategy, for Integrated Media Solutions in Los Angeles, and someone I follow on Twitter, tweeted this:
"Wow. Great article on how @astrazeneca is using Twitter to...
Will Avandia Failure Lead to More Closely Supervised Clinical Studies and Longer Patent Life...
In a BMJ editorial, editor Fiona Godlee contends that Avandia "should not have been licensed and should now be withdrawn." She cites problems that FDA discovered with the RECORD post-marketing study...
My Journey From Obesity to Normal. First Stop: Stuck in Overweight!
Because of the long holiday weekend looming here in the U.S., I anticipate that today will be pretty slow. Therefore, it's a good time to record something personal and not offend...
“Reasonable” $600 MILLION Fine for Misbranding BOTOX: I Guess Allergan’s Suit Against FDA Paid...
Allergan -- the company that markets Botox legally for wrinkles and illegally for other things -- agreed to pay $600 million in fines, including $375 million to the government as...
Pharma Email Spam: Three Degrees of Separation for Merck, Pfizer, and Genentech
Soon after I posted a blog entry and tweeted about cholesterol-lowering drugs (see here), I "coincidentally" received the following e-mail message (click for an enlarged, readable view):
I do not remember opting...
Until All of Us Have This “Blue Button,” the Online Health Revolution Has Not...
Today I will listen to the BlogTalkRadio show "E-patients, Cyberchondriacs, and Why We Should Stop Calling Names," which promises to be an "open, honest and stimulating discussion" about the "potential implications...
YouTube Fixes Problem I Pointed Out Months Ago: Update on YAZ Case Study
In January, I pointed out that drug companies that place product videos on YouTube leave themselves open to association with other videos that poke fun at them, or worse, encourage consumers...
OTC Drugs and Children
Recently, the news media and Congress focused our attention on the recall of contaminated over-the-counter (OTC) children's medication manufactured by McNeil Consumer, a division of Johnson & Johnson (see "Despite Its...
Alex Butler’s Signature Says It All — Well, Almost All.
I am getting excited about presenting at the upcoming DigiPharm Europe 2010 conference in London at the end of September mostly because I will be meeting several pharma people who are...
